Advertisement
Singapore markets closed
  • Straits Times Index

    3,300.00
    -4.00 (-0.12%)
     
  • S&P 500

    5,487.03
    +13.80 (+0.25%)
     
  • Dow

    38,834.86
    +56.76 (+0.15%)
     
  • Nasdaq

    17,862.23
    +5.21 (+0.03%)
     
  • Bitcoin USD

    66,255.02
    +1,006.44 (+1.54%)
     
  • CMC Crypto 200

    1,374.50
    -8.17 (-0.59%)
     
  • FTSE 100

    8,231.77
    +26.66 (+0.32%)
     
  • Gold

    2,352.20
    +5.30 (+0.23%)
     
  • Crude Oil

    81.73
    +0.16 (+0.20%)
     
  • 10-Yr Bond

    4.2170
    0.0000 (0.00%)
     
  • Nikkei

    38,633.02
    +62.26 (+0.16%)
     
  • Hang Seng

    18,335.32
    -95.07 (-0.52%)
     
  • FTSE Bursa Malaysia

    1,592.69
    -7.10 (-0.44%)
     
  • Jakarta Composite Index

    6,819.32
    +92.40 (+1.37%)
     
  • PSE Index

    6,344.56
    -21.47 (-0.34%)
     

INOVIO to Participate in Virtual Fireside Chat Hosted by Stephens Inc.

PLYMOUTH MEETING, Pa., June 4, 2024 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases, today announced that INOVIO's President and CEO, Dr. Jacqueline Shea, and Chief Medical Officer, Dr. Michael Sumner will participate in a virtual fireside chat hosted by Sudan Loganathan, Ph.D., Managing Director and equity research analyst at Stephens, Inc.

(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)
(PRNewsfoto/INOVIO Pharmaceuticals, Inc.)

The fireside chat will take place on Tuesday, June 11, 2024, at 11:00am ET. This event is only available to institutional clients of Stephens. Please reach out to your Stephens contact for event details.

About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of innovative DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com.

ADVERTISEMENT

Contacts
Media: Jennie Willson, (267) 429-8567, jennie.willson@inovio.com
Investors: Thomas Hong, (267) 440-4298, thomas.hong@inovio.com

Cision
Cision

View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-participate-in-virtual-fireside-chat-hosted-by-stephens-inc-302162633.html

SOURCE INOVIO Pharmaceuticals, Inc.